Maternal glucose tolerance status influences the risk of macrosomia in male but not in female fetuses


Por: Ricart, W, Lopez, J, Mozas, J, Pericot, A, Sancho, MA, Gonzalez, N, Balsells, M, Luna, R, Cortazar, A, Navarro, P, Ramirez, O, Flandez, B, Pallardo, LF, Hernandez, A, Ampudia, J, Fernandez-Real, JM, Hernandez-Aguado, I, Corcoy, R

Publicada: 1 ene 2009
Resumen:
Objective: To elucidate whether the risk of macrosomia, large for gestational age (LGA) and small for gestational age (SGA) is influenced by maternal body mass index and glucose tolerance differently in male and female fetuses. Methods: A population study was conducted in 16 general hospitals from the Spanish National Health Service that included 9270 consecutive women with singleton pregnancies and without a former diagnosis of diabetes mellitus who delivered 4793 male and 4477 female newborns. Logistic regression analyses were performed to predict the effect of body mass index (BMI) category and glucose tolerance on macrosomia, large for gestational age newborns (LGA) and small for gestational age newborns (SGA) Separate analyses according to foetal sex were carried out for each outcome. The results were adjusted for maternal age, gestational age and pregnancy-induced hypertension. Results: There were significant differences between males and females in the percentage of infants who had macrosomia, LGA or SGA. Maternal BMI category was positively associated with the risk of macrosomia and LGA in both male and female newborns. In addition, there was a negative association between maternal BMI and SGA that only reached significance in males. In contrast, gestational diabetes was only a predictor of macrosomia exclusively in male fetuses (OR 1.67, 95% CI 1.12 to 2.49) Conclusions: There is sexual dimorphism in the risk of abnormal birth weight attributed to maternal glucose tolerance status. A closer surveillance of foetal growth might be warranted in pregnant women with abnormal glucose tolerance carrying a male fetus.

Filiaciones:
Ricart, W:
 Hosp Univ Girona Dr Josep Trueta, Unit Diabet Endocrinol & Nutr, Girona 17007, Spain

Lopez, J:
 Hosp Virgen Salud, Toledo, Spain

Mozas, J:
 Hosp Univ Virgen Nieves, Granada, Spain

Pericot, A:
 Hosp Clin Univ Barcelona, Barcelona, Spain

Sancho, MA:
 Hosp Clin Univ Lozano Blesa, Zaragoza, Spain

Gonzalez, N:
 Hosp Univ Canarias, Tenerife, Spain

Balsells, M:
 Hosp Mutua Terrassa, Terrassa, Spain

Luna, R:
 Complejo Hosp Univ Xeral Cies Vigo, Vigo, Spain

Cortazar, A:
 Hosp Cruces, Baracaldo, Spain

Navarro, P:
 Hosp Gen Univ, Alicante, Spain

Ramirez, O:
 Hosp Univ Maternoinfantil Canarias, Las Palmas Gran Canaria, Spain

Flandez, B:
 Hosp Univ Getafe, Getafe, Spain

Pallardo, LF:
 Hosp La Paz, Madrid, Spain

Hernandez, A:
 Hosp Univ Dr Peset, Valencia, Spain

Ampudia, J:
 Hosp Clin Valencia, Valencia, Spain

Fernandez-Real, JM:
 Hosp Univ Girona Dr Josep Trueta, Unit Diabet Endocrinol & Nutr, Girona 17007, Spain

Hernandez-Aguado, I:
 Hosp Univ Alicante, CIBER Epidemiol & Salud Publ, Alicante, Spain

Corcoy, R:
 Hosp Santa Creu & Sant Pau, Barcelona, Spain
ISSN: 0143005X





JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH
Editorial
BMJ PUBLISHING GROUP, BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND, Reino Unido
Tipo de documento: Article
Volumen: 63 Número: 1
Páginas: 64-68
WOS Id: 000261761100012
ID de PubMed: 18718980

MÉTRICAS